205 related articles for article (PubMed ID: 27220325)
21. Correlation between topoisomerase I and tyrosyl-DNA phosphodiesterase 1 activities in non-small cell lung cancer tissue.
Jakobsen AK; Lauridsen KL; Samuel EB; Proszek J; Knudsen BR; Hager H; Stougaard M
Exp Mol Pathol; 2015 Aug; 99(1):56-64. PubMed ID: 25987486
[TBL] [Abstract][Full Text] [Related]
22. Untangling trapped topoisomerases with tyrosyl-DNA phosphodiesterases.
Zagnoli-Vieira G; Caldecott KW
DNA Repair (Amst); 2020 Oct; 94():102900. PubMed ID: 32653827
[TBL] [Abstract][Full Text] [Related]
23. Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
Zhang XR; Wang HW; Tang WL; Zhang Y; Yang H; Hu DX; Ravji A; Marchand C; Kiselev E; Ofori-Atta K; Agama K; Pommier Y; An LK
J Med Chem; 2018 Nov; 61(22):9908-9930. PubMed ID: 30336023
[TBL] [Abstract][Full Text] [Related]
24. Proteolytic degradation of topoisomerase II (Top2) enables the processing of Top2·DNA and Top2·RNA covalent complexes by tyrosyl-DNA-phosphodiesterase 2 (TDP2).
Gao R; Schellenberg MJ; Huang SY; Abdelmalak M; Marchand C; Nitiss KC; Nitiss JL; Williams RS; Pommier Y
J Biol Chem; 2014 Jun; 289(26):17960-9. PubMed ID: 24808172
[TBL] [Abstract][Full Text] [Related]
25. Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin.
Zakharenko A; Luzina O; Koval O; Nilov D; Gushchina I; Dyrkheeva N; Švedas V; Salakhutdinov N; Lavrik O
J Nat Prod; 2016 Nov; 79(11):2961-2967. PubMed ID: 27933897
[TBL] [Abstract][Full Text] [Related]
26. Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel.
Maede Y; Shimizu H; Fukushima T; Kogame T; Nakamura T; Miki T; Takeda S; Pommier Y; Murai J
Mol Cancer Ther; 2014 Jan; 13(1):214-20. PubMed ID: 24130054
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.
Nguyen TX; Abdelmalak M; Marchand C; Agama K; Pommier Y; Cushman M
J Med Chem; 2015 Apr; 58(7):3188-208. PubMed ID: 25811317
[TBL] [Abstract][Full Text] [Related]
28. TDP2 suppresses chromosomal translocations induced by DNA topoisomerase II during gene transcription.
Gómez-Herreros F; Zagnoli-Vieira G; Ntai I; Martínez-Macías MI; Anderson RM; Herrero-Ruíz A; Caldecott KW
Nat Commun; 2017 Aug; 8(1):233. PubMed ID: 28794467
[TBL] [Abstract][Full Text] [Related]
29. Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin.
El-Khamisy SF; Katyal S; Patel P; Ju L; McKinnon PJ; Caldecott KW
DNA Repair (Amst); 2009 Jun; 8(6):760-6. PubMed ID: 19303373
[TBL] [Abstract][Full Text] [Related]
30. TDP1-independent pathways in the process and repair of TOP1-induced DNA damage.
Zhang H; Xiong Y; Su D; Wang C; Srivastava M; Tang M; Feng X; Huang M; Chen Z; Chen J
Nat Commun; 2022 Jul; 13(1):4240. PubMed ID: 35869071
[TBL] [Abstract][Full Text] [Related]
31. Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors.
Kiselev E; Ravji A; Kankanala J; Xie J; Wang Z; Pommier Y
DNA Repair (Amst); 2020 Jan; 85():102747. PubMed ID: 31775111
[TBL] [Abstract][Full Text] [Related]
32. Post-translational regulation of Tyrosyl-DNA phosphodiesterase (TDP1 and TDP2) for the repair of the trapped topoisomerase-DNA covalent complex.
Bhattacharjee S; Rehman I; Nandy S; Das BB
DNA Repair (Amst); 2022 Mar; 111():103277. PubMed ID: 35101776
[TBL] [Abstract][Full Text] [Related]
33. TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function.
Gómez-Herreros F; Schuurs-Hoeijmakers JH; McCormack M; Greally MT; Rulten S; Romero-Granados R; Counihan TJ; Chaila E; Conroy J; Ennis S; Delanty N; Cortés-Ledesma F; de Brouwer AP; Cavalleri GL; El-Khamisy SF; de Vries BB; Caldecott KW
Nat Genet; 2014 May; 46(5):516-21. PubMed ID: 24658003
[TBL] [Abstract][Full Text] [Related]
34. Repair of trapped topoisomerase II covalent cleavage complexes: Novel proteasome-independent mechanisms.
Tsuda M; Kitamasu K; Hosokawa S; Nakano T; Ide H
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):170-184. PubMed ID: 31608820
[TBL] [Abstract][Full Text] [Related]
35. Discovery, enantioselective synthesis of myrtucommulone E analogues as tyrosyl-DNA phosphodiesterase 2 inhibitors and their biological activities.
Zhang Y; Yang H; Wang FT; Peng X; Liu HY; Li QJ; An LK
Eur J Med Chem; 2022 Aug; 238():114445. PubMed ID: 35580424
[TBL] [Abstract][Full Text] [Related]
36. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage.
Vance JR; Wilson TE
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13669-74. PubMed ID: 12368472
[TBL] [Abstract][Full Text] [Related]
37. Tyrosyl-DNA phosphodiesterases: rescuing the genome from the risks of relaxation.
Kawale AS; Povirk LF
Nucleic Acids Res; 2018 Jan; 46(2):520-537. PubMed ID: 29216365
[TBL] [Abstract][Full Text] [Related]
38. Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA.
Morimoto S; Tsuda M; Bunch H; Sasanuma H; Austin C; Takeda S
Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31671674
[TBL] [Abstract][Full Text] [Related]
39. Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecan.
Meisenberg C; Gilbert DC; Chalmers A; Haley V; Gollins S; Ward SE; El-Khamisy SF
Mol Cancer Ther; 2015 Feb; 14(2):575-85. PubMed ID: 25522766
[TBL] [Abstract][Full Text] [Related]
40. TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy.
Alagoz M; Wells OS; El-Khamisy SF
Nucleic Acids Res; 2014 Mar; 42(5):3089-103. PubMed ID: 24335147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
